Palmetto Addressing MoIDx Concerns

摘要

Palmetto GBA is working to address some of the concerns raised by the lab industry over its new coverage and payment program for molecular diagnostics tests, but the Medicare contractor has no plans to delay the March 1, 2012, implementation date for the program, dubbed MolDx.